NASDAQ
Infinity Pharmaceuticals, Inc. (INFIQ) has a price/sales ratio of 19.10x as of Friday, May 22, 2026. This represents a 70.67% decrease compared to its 12-month average of 65.14x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.